Results for the substance pravastatin+fenofibrate

Pravastatin + Fenofibrate is a combination medication used to treat mixed dyslipidemia, characterized by elevated LDL cholesterol and triglycerides, as well as low HDL cholesterol levels.
This combination combines the effects of the statin pravastatin, which reduces cholesterol production in the liver, with the effects of fenofibrate, which lowers triglyceride levels and increases HDL cholesterol.

This therapy is particularly indicated for patients who do not respond adequately to monotherapy with statins or fibrates and who are at high risk of cardiovascular diseases.
Pravastatin + Fenofibrate helps reduce the risk of atherosclerosis and associated complications, such as heart attack or stroke.

Side effects may include muscle pain, nausea, abdominal discomfort, and, in rare cases, rhabdomyolysis or liver dysfunction.
It is essential for patients to undergo regular liver and kidney function tests during treatment.

Patients should follow a healthy diet, avoid excessive alcohol consumption, and inform their doctor about any other medications they are taking, as the combination may interact with other treatments.
The treatment should be administered under strict medical supervision, and patients should immediately report any unusual side effects.